Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Lindeman

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Nature Communications|February 17, 2019
Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancerD Merino, T S Weber, A Serrano, et al.
Nature Communications|April 26, 2019
Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancerD Merino, T S Weber, A Serrano, et al.
Journal of Medical Genetics|June 1, 2005
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variantsP K Lovelock, S Healey, W Au, et al.
British Journal of Cancer|June 22, 2013
Tumour morphology predicts PALB2 germline mutation statusZ L Teo, E Provenzano, G S Dite, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Nature Communications|February 17, 2019
Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancerD Merino, T S Weber, A Serrano, et al.
Nature Communications|April 26, 2019
Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancerD Merino, T S Weber, A Serrano, et al.
Journal of Medical Genetics|June 1, 2005
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variantsP K Lovelock, S Healey, W Au, et al.
British Journal of Cancer|June 22, 2013
Tumour morphology predicts PALB2 germline mutation statusZ L Teo, E Provenzano, G S Dite, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
Pageof 4